Nebius welcomes Clarifai’s core team and licenses inference IP to strengthen Nebius Token Factory
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Wall St slides as oil hovers near $100 on rising Middle East tensions
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Oil nears $100 as fresh Middle East strikes raise supply risks
- How big a risk are rates to the AI boom?
- 3 reasons why S&P 500 may drop up to 10% in the near term: RBC
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Wolfe on Nebius (NBIS) Amid 19% Gain: 'We think contracted capacity turning active is difficult to underwrite'
May 13, 2026 1:45 PM EDTWolfe Research analyst Arsenije Matovic reiterated a Peerperform rating and {REMOVEPT} price target on Nebius Group (NASDAQ: NBIS).
The analyst comments "Overview. NBIS reported 1Q results with revenue of $399M, up 684% Y/Y (+6% vs. cons.), and ARR reaching $1.9B, up >50% Q/Q, supported by added capacity, increased utilization, and higher pricing. NBIS raised FY26 CapEx guidance by $4.5B at the midpoint to $20-25B, driven by FY27 demand visibility rather than component costs, while reiterating FY26... More
